Hesai Group will release Q3 2026 financial results on November 10, 2026, with a conference call at 7:00 AM ET.
Alvotech received FDA approval for a new manufacturing process for its biosimilar SIMLANDI® (adalimumab-ryvk). The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results